
Lisa V. Cook
Examiner (ID: 4135, Phone: (571)272-0816 , Office: P/1678 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1677, 1641, 1678 |
| Total Applications | 1359 |
| Issued Applications | 795 |
| Pending Applications | 176 |
| Abandoned Applications | 414 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20068950
[patent_doc_number] => 20250207172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => METHOD FOR DETERMINING AMOUNTS OF NAD METABOLITES FROM SAMPLE AND METHODS AND USES RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 19/037543
[patent_app_country] => US
[patent_app_date] => 2025-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19037543
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/037543 | METHOD FOR DETERMINING AMOUNTS OF NAD METABOLITES FROM SAMPLE AND METHODS AND USES RELATED THERETO | Jan 26, 2025 | Pending |
Array
(
[id] => 19711880
[patent_doc_number] => 20250022022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => ACTIVATION OF BIOLUMINESCENCE BY STRUCTURAL COMPLEMENTATION
[patent_app_type] => utility
[patent_app_number] => 18/890453
[patent_app_country] => US
[patent_app_date] => 2024-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18890453
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/890453 | Activation of bioluminescence by structural complementation | Sep 18, 2024 | Issued |
Array
(
[id] => 19541773
[patent_doc_number] => 20240358809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => CANCER VACCINES TARGETING SURVIVIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/765553
[patent_app_country] => US
[patent_app_date] => 2024-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/765553 | CANCER VACCINES TARGETING SURVIVIN AND USES THEREOF | Jul 7, 2024 | Pending |
Array
(
[id] => 19526699
[patent_doc_number] => 20240350601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => Therapeutic Anticancer Neoepitope Vaccine
[patent_app_type] => utility
[patent_app_number] => 18/738685
[patent_app_country] => US
[patent_app_date] => 2024-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738685
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/738685 | Therapeutic Anticancer Neoepitope Vaccine | Jun 9, 2024 | Pending |
Array
(
[id] => 19432548
[patent_doc_number] => 20240301046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => ANTI-AMYLOID BETA PROTOFIBRIL/OLIGOMER ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/652576
[patent_app_country] => US
[patent_app_date] => 2024-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 554
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652576
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652576 | ANTI-AMYLOID BETA PROTOFIBRIL/OLIGOMER ANTIBODIES AND USES THEREOF | Apr 30, 2024 | Abandoned |
Array
(
[id] => 20109397
[patent_doc_number] => 12360109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => System and sensor array
[patent_app_type] => utility
[patent_app_number] => 18/644619
[patent_app_country] => US
[patent_app_date] => 2024-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 143
[patent_figures_cnt] => 128
[patent_no_of_words] => 40425
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18644619
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/644619 | System and sensor array | Apr 23, 2024 | Issued |
Array
(
[id] => 19512319
[patent_doc_number] => 20240344005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => DEVICES, SYSTEMS AND METHODS FOR INHIBITING INVASION AND METASTASES OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/631480
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -94
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631480
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/631480 | DEVICES, SYSTEMS AND METHODS FOR INHIBITING INVASION AND METASTASES OF CANCER | Apr 9, 2024 | Pending |
Array
(
[id] => 20151561
[patent_doc_number] => 20250251399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-07
[patent_title] => BIOMARKERS FOR PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 18/624620
[patent_app_country] => US
[patent_app_date] => 2024-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18624620
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/624620 | BIOMARKERS FOR PANCREATIC CANCER | Apr 1, 2024 | Pending |
Array
(
[id] => 19425089
[patent_doc_number] => 12084492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Anti-amyloid beta protofibril/oligomer antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/417299
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 26
[patent_no_of_words] => 19310
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 536
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417299
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417299 | Anti-amyloid beta protofibril/oligomer antibodies and uses thereof | Jan 18, 2024 | Issued |
Array
(
[id] => 19114035
[patent_doc_number] => 20240125785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => COMPOSITIONS AND METHODS TO DETECT HEAD AND NECK CANCER
[patent_app_type] => utility
[patent_app_number] => 18/398016
[patent_app_country] => US
[patent_app_date] => 2023-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18398016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/398016 | COMPOSITIONS AND METHODS TO DETECT HEAD AND NECK CANCER | Dec 26, 2023 | Pending |
Array
(
[id] => 19302079
[patent_doc_number] => 20240230656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => Predicting Prognosis and Treatment Response of Breast Cancer Patients Using Expression and Cellular Localization of N-Myristoyltransferase
[patent_app_type] => utility
[patent_app_number] => 18/537241
[patent_app_country] => US
[patent_app_date] => 2023-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18537241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/537241 | Predicting Prognosis and Treatment Response of Breast Cancer Patients Using Expression and Cellular Localization of N-Myristoyltransferase | Dec 11, 2023 | Pending |
Array
(
[id] => 19081963
[patent_doc_number] => 20240108764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic colorectal cancer model
[patent_app_type] => utility
[patent_app_number] => 18/524613
[patent_app_country] => US
[patent_app_date] => 2023-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18524613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/524613 | 3E8.scFv.Cys-IR800 conjugate targeting TAG-72 in an orthotopic colorectal cancer model | Nov 29, 2023 | Issued |
Array
(
[id] => 20227982
[patent_doc_number] => 12416631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Immunoassay-based determination of in-solution binding kinetics
[patent_app_type] => utility
[patent_app_number] => 18/523859
[patent_app_country] => US
[patent_app_date] => 2023-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4002
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 352
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18523859
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/523859 | Immunoassay-based determination of in-solution binding kinetics | Nov 28, 2023 | Issued |
Array
(
[id] => 20329751
[patent_doc_number] => 12460017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/507167
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 34
[patent_no_of_words] => 28571
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507167
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/507167 | Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof | Nov 12, 2023 | Issued |
Array
(
[id] => 18903960
[patent_doc_number] => 20240019445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => DEVICE AND METHOD FOR DETECTION OF ANALYTES
[patent_app_type] => utility
[patent_app_number] => 18/372933
[patent_app_country] => US
[patent_app_date] => 2023-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18372933
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/372933 | Device and method for detection of analytes | Sep 25, 2023 | Issued |
Array
(
[id] => 19235027
[patent_doc_number] => 20240192221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PROTEIN SEQUENCING METHOD AND REAGENTS
[patent_app_type] => utility
[patent_app_number] => 18/473207
[patent_app_country] => US
[patent_app_date] => 2023-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18473207
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/473207 | PROTEIN SEQUENCING METHOD AND REAGENTS | Sep 21, 2023 | Pending |
Array
(
[id] => 19035608
[patent_doc_number] => 20240085423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER
[patent_app_type] => utility
[patent_app_number] => 18/468096
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18468096
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/468096 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER | Sep 14, 2023 | Pending |
Array
(
[id] => 19355106
[patent_doc_number] => 12055541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => System and sensor array
[patent_app_type] => utility
[patent_app_number] => 18/460221
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 143
[patent_figures_cnt] => 128
[patent_no_of_words] => 45436
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460221 | System and sensor array | Aug 31, 2023 | Issued |
Array
(
[id] => 18956558
[patent_doc_number] => 20240044885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => SYSTEM AND SENSOR ARRAY
[patent_app_type] => utility
[patent_app_number] => 18/460254
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460254
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460254 | SYSTEM AND SENSOR ARRAY | Aug 31, 2023 | Pending |
Array
(
[id] => 18902779
[patent_doc_number] => 20240018264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/359380
[patent_app_country] => US
[patent_app_date] => 2023-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18359380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/359380 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER | Jul 25, 2023 | Pending |